from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1813c/-

LFCtreatmentdescriptionclass of inhibitor

0.185

Amikacinug/mL Amikacintranslation

-0.212

Cap5-10ug/mL Capreomycintranslation

0.522

Rox10-50 ug/mL Roxithromycintranslation

0.099

SM2-5 ug/mL Streptomycintranslation

1.136

Tet5-10 ug/mL Tetracyclinetranslation

0.070

Rif0.2-5ug/mL Rifampicintranscription

-0.050

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.515

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.061

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.426

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.414

Clofazimine10-13 ug/mL Clofaziminerespiration

0.029

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.364

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.298

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.729

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.040

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.381

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.270

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.277

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.052

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.768

KCN5-20 ug/mL Potassium cyaniderespiration

-0.823

NaN30.2-2 mM Sodium aziderespiration

-0.741

Nigericin50 uM Nigericinrespiration

-0.313

TRC10-150 ug/mL Triclosanrespiration

-0.246

TRZ10-25 ug/mL Thioridazinerespiration

1.043

Valinomycin0.5-10 uM Valinomycinrespiration

1.121

ZnSO42 mM ZnSO4respiration

-0.001

menadione6-10 ug/mL Menadionerespiration

-0.225

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.460

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.099

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.976

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

4.112

NRP_1Non-replicating persistence stage 1dosRassociated

-0.331

Amp0.2mg/mL AmpicillincellWall

-0.251

Cephalexin20-100 ug/mL CephalexincellWall

0.297

Cerulenin0.32-5 ug/mL CerulenincellWall

0.084

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.492

EMB10-20 ug/mL EthambutolcellWall

-0.137

Eta12-40 ug/mL EthionamidecellWall

-0.464

INH0.2-0.4 ug/mL IsoniazidcellWall

0.159

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.664

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.057

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.166

BZA0.12 mg/mL BenzamidearomaticAmides

-0.904

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.714

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.273

H2O24 mM hydrogen peroxideDNAdamaging

-0.411

Levo10 ug/mL LevofloxacinDNAdamaging

-0.358

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.454

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.063

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.166

UVUV-irradiationDNAdamaging

0.843

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.531

Antimycin12.5-50 ug/mL Antimycin A?

-0.076

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.575

PA_110-50 ug/mL Antitubercular compound PA-1?

0.018

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.971

PA8240.2-2 ug/mL PA-824?

2.952

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.585

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.225

Verapamil50 uM Verapamil?

-0.590

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.670

methoxatin10-20 ug/mL Methoxatin?